SCHEMBL14725732

SCHEMBL14725732

c1ccc(-n2c3ccccc3c3cc(-c4cc5cc6c(cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)c7c6ccc6c8ccccc8oc67)cc5c5ccc6c7ccccc7oc6c45)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ALOX5 P09917 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ BRCA1 P38398 1/20 0.36
▸ PRKDC P78527 1/20 0.33
▸ PPARG P37231 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NR2E3 Q9Y5X4 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ SIRT2 Q8IXJ6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725658 0.91 KDM4E (0.39) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL16472814 0.85 KDM4E (0.36) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL14725705 0.85 KDM4E (0.36) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL16472690 0.84 KDM4E (0.33) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL15338033 0.84 KDM4E (0.45) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL16472723 0.83 KDM4E (0.33) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL15946257 0.83 KDM4E (0.33) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL15450180 0.83 ALOX5 (0.37) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL16574980 0.83 KDM4E (0.42) KDM4EL3MBTL1ATMALOX5ALDH1A1
SCHEMBL23502166 0.83 KDM4E (0.42) KDM4EL3MBTL1ATMALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 KDM4E 1981/4885L3MBTL1 1029/4885ATM 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback